AlphaStocks
5.8
Consider Buy

Zimmer Biomet Holdings, Inc. (ZBH)

As of Sep 20, 2026, Zimmer Biomet Holdings, Inc. (ZBH) scores 5.8/10 on AlphaStocks' five-model composite, #60 of 168 Health Care stocks. At $95, ZBH trades 1% above its model fair value of $95.

Health Care / Health Care Equipment

S&P 500

$95.39

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#60out of 168 in Health Care

Is ZIMMER BIOMET HOLDINGS, INC. a Good Investment in 2026?

ZIMMER BIOMET HOLDINGS, INC. (ZBH) scores 5.8 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates ZIMMER BIOMET HOLDINGS, INC. as Strong (Earnings yield 14.7% · ROC 78%). The Lynch model is the least favorable, rating it Neutral. ZIMMER BIOMET HOLDINGS, INC. currently trades 1% above its estimated fair value of $95. ZIMMER BIOMET HOLDINGS, INC. ranks #60 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E26.9ROE5.5Market Cap19BDiv Yield1.0

Estimated Fair Value

$94.681% above

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

28% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Strong

Earnings yield 14.7% · ROC 78%

Frequently Asked Questions

Is ZIMMER BIOMET HOLDINGS, INC. (ZBH) a good investment?
As of Sep 20, 2026, Zimmer Biomet Holdings, Inc. (ZBH) scores 5.8/10 on AlphaStocks' five-model composite, #60 of 168 Health Care stocks. At $95, ZBH trades 1% above its model fair value of $95. That is a middle-of-the-pack score with no strong signal either way.
What is ZIMMER BIOMET HOLDINGS, INC.'s Piotroski F-Score?
ZIMMER BIOMET HOLDINGS, INC.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ZBH overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $95, ZBH appears overvalued. The stock currently trades 1% above its estimated fair value. Trading near estimated fair value.
How does ZBH compare to other Health Care stocks?
ZIMMER BIOMET HOLDINGS, INC. ranks #60 out of 168 stocks in the Health Care sector, placing it in the top 36% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about ZBH?
AlphaStocks evaluates ZBH using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.8/10.

Similar Stocks

INSPUFPTBDX

Compare ZBH with

INSP vs ZBHUFPT vs ZBHBDX vs ZBH

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer